about
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesNitroxyl inhibits overt pain-like behavior in mice: role of cGMP/PKG/ATP-sensitive potassium channel signaling pathway.Phytochemical analysis and antinociceptive properties of the seeds of Garcinia achachairu.Distribution of endogenous farnesyl pyrophosphate and four species of lysophosphatidic acid in rodent brain.Photobiomodulation therapy in the modulation of inflammatory mediators and bradykinin receptors in an experimental model of acute osteoarthritis.Experimental evaluation of analgesic and anti-inflammatory activity of simvastatin and atorvastatin.IL-33 mediates antigen-induced cutaneous and articular hypernociception in miceThe nitroxyl donor, Angeli's salt, inhibits inflammatory hyperalgesia in rats.Neuro, cardio, and reno protective activities of rosuvastatin in streptozotocin-induced type 2 diabetic rats undergoing treatment with metformin and glimepiride.Antinociceptive and antidiarrheal effects of pioglitazone in a rat model of diarrhoea-predominant irritable bowel syndrome: role of nitric oxide.Atorvastatin inhibits the inflammatory response caused by anti-M(3) peptide IgG in patients with primary Sjögren's syndrome.Neuroprotective and anti-inflammatory activities of atorvastatin in a rat chronic constriction injury model.Antihyperalgesic and anti-inflammatory effects of atorvastatin in chronic constriction injury-induced neuropathic pain in rats.Atorvastatin exerts anti-nociceptive activity and decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-α in a rat endometriosis model.Aspirin alone and combined with a statin suppresses eicosanoid formation in human colon tissue.The ruthenium nitric oxide donor, [Ru(HEDTA)NO], inhibits acute nociception in mice by modulating oxidative stress, cytokine production and activating the cGMP/PKG/ATP-sensitive potassium channel signaling pathway.
P2860
Q28388335-0BA6A612-4D21-4176-8FF1-09E0D289AEE7Q33925515-0E3CF833-FBF1-4904-A95E-40E5632D2689Q34254300-6FF280A3-9679-4CBC-A2CB-E100AD97133AQ34378141-731E405B-E97C-43DB-9ECE-F0F1F163C7CCQ36160155-423B1470-151B-4999-8BAC-18548C27DFBDQ36313477-C7C876BF-862E-4A05-94AE-02026533D49BQ36497523-F3C87E21-E731-4DE2-816D-8CC74D1CDFF3Q36884713-B78BA0ED-6354-4D3D-8071-83CD25E380C0Q40952745-61802CF3-3868-4280-A028-D082A03CC877Q43312030-0D55A800-C1D2-4958-BC1F-DCBC5BCBF42FQ43826601-A6F6A554-C676-4C50-8DB1-620336D13304Q44225729-82C13E56-5BC6-49D1-8F73-A47BF01A2F48Q47968774-0E139690-3333-4B18-90BC-368EDA6A9238Q51135178-C4106F32-122F-448D-A193-BC7F3A732196Q52809890-5D1FFF06-534C-499F-998D-BD4E16718DF6Q54331336-898F4780-3768-45CB-96A2-FACD1B21B239
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Atorvastatin inhibits inflammatory hypernociception.
@ast
Atorvastatin inhibits inflammatory hypernociception.
@en
type
label
Atorvastatin inhibits inflammatory hypernociception.
@ast
Atorvastatin inhibits inflammatory hypernociception.
@en
prefLabel
Atorvastatin inhibits inflammatory hypernociception.
@ast
Atorvastatin inhibits inflammatory hypernociception.
@en
P2093
P2860
P356
P1476
Atorvastatin inhibits inflammatory hypernociception
@en
P2093
C A Parada
D A R Valério
S H Ferreira
T Santodomingo-Garzón
P2860
P356
10.1038/SJ.BJP.0706836
P407
P577
2006-07-24T00:00:00Z